BMY · Healthcare
Bristol-Myers Squibb Co
25/100
Smart-money confidence1 of 3 sources positive
Below average interest
No standout activity across the feeds we track.
What this band has actually done: stocks scoring 25–45 beat the S&P 500 over the next three months 45.3% of the time, across 39,662 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this
Hedge funds
34
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$124.4B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NYSE
About BRISTOL-MYERS SQUIBB CO
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of relapsed or refractory large B-cell…
Who's behind the signal
Every informed buyer we can see on BMY, across all three feeds.
Hedge funds · 7
Tweedy Browne
Increased +44%
Gotham Asset Mgmt (Greenblatt)
Increased +4%
Citadel Advisors
Increased +5%
D.E. Shaw & Co
Increased +80%
AQR Capital Management
Decreased −8%
Millennium Management (Englander)
Decreased −88%
+1 more in the full breakdown below ↓
Congress · 26
Mike Kelly
sold
Alan Armstrong
bought
Gilbert Ray Cisneros, Jr.
bought
Julie Johnson
sold
Virginia Foxx
sold
Jefferson Shreve
sold
Julia Letlow
sold
Tommy Tuberville
sold
+18 more in the full record below ↓
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 50 on record
Disclosures from 2020-03-13 to 2026-05-07
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2026-05-07 | Mike Kelly · R-PA | House | Sold | $15,001 - $50,000 |
| 2026-03-27 | Alan Armstrong · R-OK | Senate | Bought | $1,001 - $15,000 |
| 2025-12-19 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2025-12-18 | Julie Johnson · D-TX | House | Sold | $1,001 - $15,000 |
| 2025-11-13 | Julie Johnson · D-TX | House | Sold | $1,001 - $15,000 |
| 2025-11-12 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2025-10-09 | Gilbert Ray Cisneros, Jr. · D-CA | House | Sold | $1,001 - $15,000 |
| 2025-08-14 | Julie Johnson · D-TX | House | Sold | $1,001 - $15,000 |
| 2025-06-24 | Virginia Foxx · R-NC | House | Sold | $1,001 - $15,000 |
| 2025-05-12 | Jefferson Shreve · R-IN | House | Sold | $15,001 - $50,000 |
Show the other 40
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2025-04-28 | Julia Letlow · R-LA | House | Sold | $1,001 - $15,000 |
| 2025-04-15 | Tommy Tuberville · R-AL | Senate | Sold | $1,001 - $15,000 |
| 2025-04-01 | Julie Johnson · D-TX | House | Sold | $1,001 - $15,000 |
| 2025-03-27 | Greg Landsman · D-OH | House | Sold | $1,001 - $15,000 |
| 2025-01-15 | Julie Johnson · D-TX | House | Bought | $1,001 - $15,000 |
| 2024-12-06 | Virginia Foxx · R-NC | House | Bought | $1,001 - $15,000 |
| 2024-10-29 | Val T. Hoyle · D-OR | House | Bought | $1,001 - $15,000 |
| 2024-10-23 | Julia Letlow · R-LA | House | Bought | $1,001 - $15,000 |
| 2024-01-18 | John James · R-MI | House | Sold | $1,001 - $15,000 |
| 2024-01-09 | Rick Larsen · D-WA | House | Sold | $1,001 - $15,000 |
| 2023-11-10 | John James · R-MI | House | Bought | $1,001 - $15,000 |
| 2023-10-24 | Greg Stanton · D-AZ | House | Sold | $1,001 - $15,000 |
| 2023-09-26 | Greg Stanton · D-AZ | House | Bought | $1,001 - $15,000 |
| 2023-07-12 | Daniel S. Goldman · D-NY | House | Sold | $15,001 - $50,000 |
| 2023-04-10 | Daniel S. Goldman · D-NY | House | Bought | $50,001 - $100,000 |
| 2023-03-07 | Daniel S. Goldman · D-NY | House | Sold | $1,001 - $15,000 |
| 2023-03-06 | Daniel S. Goldman · D-NY | House | Sold | $100,001 - $250,000 |
| 2022-11-28 | Van Taylor · R-TX | House | Sold | $100,001 - $250,000 |
| 2022-07-15 | Kathy E. Manning · D-NC | House | Bought | $1,001 - $15,000 |
| 2022-03-16 | John H. Rutherford · R-FL | House | Sold | $1,001 - $15,000 |
| 2021-11-10 | Carol D. Miller · R-WV | House | Sold | $15,001 - $50,000 |
| 2021-10-28 | Kim Schrier · D-WA | House | Sold | $1,001 - $15,000 |
| 2021-06-07 | Thomas R. Suozzi · D-NY | House | Sold | $1,001 - $15,000 |
| 2021-06-04 | Thomas R. Suozzi · D-NY | House | Sold | $1,001 - $15,000 |
| 2021-02-05 | Kurt Schrader · D-OR | House | Bought | $1,001 - $15,000 |
| 2020-11-25 | Rick Larsen · D-WA | House | Bought | $1,001 - $15,000 |
| 2020-11-19 | Kenny Marchant · R-TX | House | Bought | $15,001 - $50,000 |
| 2020-10-22 | George Holding · R-NC | House | Sold | $1,001 - $15,000 |
| 2020-10-22 | Katherine M. Clark · D-MA | House | Sold | $1,001 - $15,000 |
| 2020-08-14 | George Holding · R-NC | House | Sold | $1,001 - $15,000 |
| 2020-07-30 | Thomas R. Suozzi · D-NY | House | Sold | $1,001 - $15,000 |
| 2020-07-10 | Thomas R. Suozzi · D-NY | House | Sold | $1,001 - $15,000 |
| 2020-06-21 | John H. Rutherford · R-FL | House | Bought | $1,001 - $15,000 |
| 2020-04-16 | David Perdue · R-GA | Senate | Sold | $1,001 - $15,000 |
| 2020-04-14 | David Perdue · R-GA | Senate | Sold | $15,001 - $50,000 |
| 2020-04-14 | Kelly Loeffler · R-GA | Senate | Sold | $100,001 - $250,000 |
| 2020-04-14 | Kelly Loeffler · R-GA | Senate | Sold | $250,001 - $500,000 |
| 2020-04-03 | Katherine M. Clark · D-MA | House | Bought | $1,001 - $15,000 |
| 2020-03-18 | Gilbert Ray Cisneros, Jr. · D-CA | House | Sold | $1,001 - $15,000 |
| 2020-03-13 | Van Taylor · R-TX | House | Sold | $100,001 - $250,000 |
Not a model pick — but on our radar.
BRISTOL-MYERS SQUIBB CO isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
0
New positions
4
Increasing
3
Decreasing
0
Unchanged
Price History
Loading price data...
A member of Congress bought
A member sold
Return:
High:
Low:
Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.2×
% of portfolio
0.2%
Position change
+44%
0.2% of Tweedy Browne's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+4%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+5%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+80%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.6%
Position change
−8%
0.6% of AQR Capital Management's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−88%
0.0% of Millennium Management's portfolio
Trust weight: 1.2×
% of portfolio
0.0%
Position change
−99%
0.0% of Dodge & Cox's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to BRISTOL-MYERS SQUIBB CO
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell BRISTOL-MYERS SQUIBB CO or any security.
订阅每周更新
我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费，直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订